Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast Cancer
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-15-3036
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2016
Authors
Publisher
American Association for Cancer Research (AACR)